about
Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trialsImpact of vitamin D on infectious diseaseAdaptive immunity to fungiControl of adaptive immunity by the innate immune systemThe temporal dynamics of differential gene expression in Aspergillus fumigatus interacting with human immature dendritic cells in vitroEarly-expressed chemokines predict kidney immunopathology in experimental disseminated Candida albicans infectionsTherapy of murine pulmonary aspergillosis with antibody-alliinase conjugates and alliin.Selective C-Rel activation via Malt1 controls anti-fungal T(H)-17 immunity by dectin-1 and dectin-2.Dynamic interplay among monocyte-derived, dermal, and resident lymph node dendritic cells during the generation of vaccine immunity to fungi.In pulmonary paracoccidioidomycosis IL-10 deficiency leads to increased immunity and regressive infection without enhancing tissue pathology.Epidemiology and treatment approaches in management of invasive fungal infectionsGene expression profiles of human dendritic cells interacting with Aspergillus fumigatus in a bilayer model of the alveolar epithelium/endothelium interfaceSpecific alterations in complement protein activity of little brown myotis (Myotis lucifugus) hibernating in white-nose syndrome affected sites.Cytokines induce effector T-helper cells during invasive aspergillosis; what we have learned about T-helper cells?Agaricus subrufescens: A reviewDectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection.Regulation of interleukin-12/interleukin-23 production and the T-helper 17 response in humans.Massive induction of innate immune response to Candida albicans in the kidney in a murine intravenous challenge model.The SOCS3-independent expression of IDO2 supports the homeostatic generation of T regulatory cells by human dendritic cells.Neutrophils and macrophages work in concert as inducers and effectors of adaptive immunity against extracellular and intracellular microbial pathogens.Cracking the Toll-like receptor code in fungal infections.IL-22 in antifungal immunity.T cell immunity and vaccines against invasive fungal diseases.Innate immunity against moulds: lessons learned from invertebrate models.Challenges in the therapy of chromoblastomycosis.Severe Paracoccidioidomycosis in a 14-Year-Old Boy.Overlooked Mechanisms in Type 1 Diabetes Etiology: How Unique Costimulatory Molecules Contribute to DiabetogenesisEnhancement of anti-Aspergillus T helper type 1 response by interferon-β-conditioned dendritic cells.Immunobiological Activity of Synthetically Prepared Immunodominant Galactomannosides Structurally Mimicking Aspergillus Galactomannan.A Multifaceted Role of Tryptophan Metabolism and Indoleamine 2,3-Dioxygenase Activity in Aspergillus fumigatus-Host Interactions.Correlation Between β-Glucan and Neutrophil/Eosinophil Ratio of Paranasal Sinus Mucosa and Blood in the Diagnosis of Chronic Fungal Rhinosinusitis
P2860
Q24634794-E22ED26C-BC35-4AF5-9D20-35C01FA18352Q27000724-EEC8EA52-D0D4-494F-BC41-A9776F1CD355Q27025806-159847AF-57DF-4325-8E7E-489DC436C216Q27026513-24E261B6-E845-4FC7-94E9-353C039A0885Q28476745-5B22581A-D030-42EF-AB32-D28F4C7F14B9Q33488522-872072DE-D277-4034-9645-B78C6A030C28Q33613647-35C2282E-8B38-433F-9946-DBBB7F7B6F57Q33809396-F3DBECF7-F222-4ADA-A34E-A2C196B0E2E0Q33957860-4F1880EB-59DA-45BB-8F96-898FD0C9ADBBQ35037044-4E2A5F80-3541-41CD-A17F-13E72C2A5E0AQ35089772-232D3B55-2FA8-44FD-81EA-76C250B05C7AQ35175339-125EC4F4-5173-41C7-8D5C-6B908189CC67Q35582719-D59025E5-BE10-4737-A359-12418675102EQ35591125-1C49D14B-1940-4978-A57F-C1A2642DCD98Q37062458-C05DEE0F-B837-4D1B-86BB-BF4D159A0C2EQ37331568-106256A4-62DD-4A4A-943C-708F204EB02CQ37374938-E23E9BDA-BBCB-42CC-BD37-6BD148FA9B14Q37442471-8B71FC30-110D-42AD-A318-4603CB25D88DQ37528354-0293C6DE-26DC-469F-B172-B62F974E4979Q37683238-C4D2BA8F-0AC7-487B-A0C5-A1F6E05FA002Q37800920-EBBD1D7E-43B4-4E42-813E-CDB84AB2242AQ37832449-676A0D5C-8B7D-459C-9CF6-BA8D4C2DD433Q37911513-2EAFE3E4-9FE0-46D7-A289-309B9176BE1BQ37943844-F03A905B-32D2-464A-BB1D-A27FD168FBF4Q38103473-25B79716-F494-4274-90B5-5387F9155FF5Q40629624-E98B7C51-F931-46DE-8222-97219DAF747FQ41526144-6E7E781E-77D5-469A-BA4F-FE47283E5322Q42662541-915DF8B4-4D54-4D71-9EA9-1AFD2EDDC6B5Q42683287-775CFD67-89D4-46D3-B553-7F84372E6884Q49332493-A82C3912-E8C7-4C48-A8A6-46EFCEB44254Q58775505-D08D46EA-BA0D-46E8-B6DF-B0BB946F6087
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cell mediated immunity to fungi: a reassessment.
@en
Cell mediated immunity to fungi: a reassessment.
@nl
type
label
Cell mediated immunity to fungi: a reassessment.
@en
Cell mediated immunity to fungi: a reassessment.
@nl
prefLabel
Cell mediated immunity to fungi: a reassessment.
@en
Cell mediated immunity to fungi: a reassessment.
@nl
P2860
P1433
P1476
Cell mediated immunity to fungi: a reassessment.
@en
P2860
P304
P356
10.1080/13693780801971450
P577
2008-09-01T00:00:00Z